Cranfield Aerospace Solutions’ (CAeS) appointment of Richard Moody in a newly created role of Chief Investment Officer will drive forward the organisation’s goal of developing the world's first zero emissions, regulatory certified, commercially viable, Hydrogen aircraft.
Richard Moody joins CAeS with over 25 years of global financial leadership experience in investment banking organisations with responsibility for providing leadership in respect of investor relations, strategic investments and capital raising.
Most recently, Richard was Global Head of Transportation Finance at Deutsche Bank (DB) overseeing a team of professionals in London, New York, Singapore and Hamburg and working with operators, lessors, developers and investors across private and public capital markets. In his career at DB, he has successfully raised and financed over US$75 billion across the transportation and infrastructure sectors globally.
He previously served as the Co-Head of Transportation, Infrastructure and Energy (TIE) Financing for EMEA/Americas. Richard was a member of DB’s Global Credit Financing Solutions Management Committee and Chairman of the Global Transportation Investment Committee.
Richard was also the Global Credit Trading lead in helping to develop DB’s transportation sustainable framework and represented the bank on the Aviation Working Group (AWG) an NGO focused on international aviation financing and leasing including sustainability issues.
“Sustainability and decarbonisation are the major generational themes in the aviation industry today and Cranfield has the engineering and aerospace expertise to play a significant part in this critical agenda. I am delighted to be joining the company at this exciting time as it seeks to develop the world’s first commercially viable hydrogen aircraft” said Richard Moody.
Paul Hutton, CEO commented “Cranfield Aerospace is leading the introduction of zero-emissions hydrogen propulsion into commercial aircraft, and Richard’s leadership, expertise and experience from the financial sector will be a key attribute as we look to scale the company and raise further capital and develop the commercial partnerships needed to deliver our vision.”